GSK Stockmann has advised the shareholders of Beams Technology GmbH, Berlin, Germany, on their divestment to Insight Partners and Liberty Hall Capital Partners backed Comply365 Group. Comply365 is a leading provider of Operational Content Management, Safety Management and Training Management in the highly regulated industries of aviation, defense, rail and space.
Beams has pioneered a Safety AI solution for the aviation industry to automate safety data processing and enable proactive, predictive risk management. The acquisition accelerates Comply365’s investment in the development of an industry-first, AI platform across operations, safety, and training management. More details can be found in the official deal notification.
A GSK Stockmann team led by Berlin-based partner Robert Korndörfer advised the Beams shareholders on all legal and tax aspects of the divestment.
GSK Stockmann’s M&A/private equity team regularly advises strategic investors and financial sponsors on domestic and cross-border buy-out and exit transactions. It consists of more than 50 lawyers working together seamlessly across our seven offices and all practice areas of GSK Stockmann.
Advisers of the shareholders of Beams Technology GmbH at GSK Stockmann:
Robert Korndörfer (lead, Partner, Corporate), Daniel Fehling (Partner, Corporate), Stephan Wachsmuth (Local Partner, Tax), Dominik Berka (Local Partner, Tax), Nicole Deparade (Local Partner, Employment), Dr Martin Hossenfelder (Counsel, IP/IT); Clara López Hernando (Senior Associate, Corporate), Raphaela Guderian (Associate, Employment), Katrin Zukovskaja (Associate, Employment)
Other advisers:
Willkie Farr & Gallagher for the Comply365 Group
